"granules-india-ltd"

Granules announced that US Food & Drug Administration (US FDA) has approved its ANDA for Venlafaxine Hydrochloride Extended-Release Capsules.

Income from operations went up 16 per cent year-on-year, despite shortage of raw materials, lower utilisation capacities in paracetamol and logistic disruptions